Application of Biomarkers in Neurological Diseases

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-06-05

Study Completion Date

2031-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To explore the predictive and diagnostic role of biomarkers in patients with neurological diseases.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Diagnostic and Prognostic Biomarkers for High-impact Chronic Pain: Development and Validation

NCT04994249

Chronic Musculoskeletal Pain Pain Pain, Chronic +1 more

RECRUITING

Large-scale Multi-omics Analysis of Cerebrospinal Fluid

NCT06636201

Aging

RECRUITING

Gut Microbiota in Patients With Moyamoya Disease

NCT04890782

Moyamoya Disease Gut Microbiota

UNKNOWN

Evaluation of the Vulnerable Carotid Atherosclerotic Plaque: A Clinical Multicenter Study

NCT05849909

Ultrasound

UNKNOWN

Biomarkers and Validation of Selected Outcome Measures (CMTNSmod)

NCT03386266

Charcot-Marie-Tooth Disease, Type IA

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

With the rise and continuous development of omics technology and bioinformatics technology, some scholars have applied proteomics technology and metabolomics technology to study the brain tissue, plasma and CSF of patients with nervous system diseases, so as to screen out potential biomarkers, with a view to providing new research ideas for pathogenesis and early diagnosis of neurological diseases. At present, the research on some novel biomarkers is still in its infancy, and many key problems remain to be solved. It is necessary to further determine the expression level of biomarkers in normal human body and the characteristics of biomarkers in patients with neurological diseases.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Biomarkers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients admitted to hospital/emergency department with neurological diseases

All clinical data, laboratory data and imaging data of patients at baseline and follow-up were collected, as well as blood and tissue samples that did not affect the diagnosis and treatment of patients after obtaining the consent of patients at different time points in the acute and chronic phases.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients with neurological diseases;
2. Subjects or legal agents agree to participate in the study and sign the informed consent.

Exclusion Criteria

1. Participating in other clinical investigators;
2. Unwilling to be followed up or poor treatment compliance;
3. Other conditions considered unsuitable for inclusion by the researchers.

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes